Health Care & Life Sciences » Pharmaceuticals | Zomedica Pharmaceuticals Corp.

Zomedica Pharmaceuticals Corp. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
Cost of Goods Sold (COGS) incl. D&A
-
-
-
-
Gross Income
-
-
-
-
SG&A Expense
1.40
86.20
53.10
73.90
EBIT
1.40
86.20
53.10
73.90
Unusual Expense
-
-
-
-
Non Operating Income/Expense
-
-
-
-
Pretax Income
1.40
86.20
53.10
73.90
Consolidated Net Income
1.40
86.20
53.10
73.90
Net Income
1.40
86.20
53.10
73.90
Net Income After Extraordinaries
1.40
86.20
53.10
73.90
Net Income Available to Common
1.40
86.20
53.10
73.90
EPS (Basic)
0.00
0.25
0.05
0.07
Basic Shares Outstanding
1,800.00
337.00
1,000.00
1,000.00
EPS (Diluted)
0.00
0.26
0.05
0.07
Diluted Shares Outstanding
1,800.00
337.00
1,000.00
1,000.00
EBITDA
1.40
86.20
53.10
73.90

About Zomedica Pharmaceuticals

View Profile
Address
100 Phoenix Drive
Ann Arbor Michigan 48108
United States
Employees -
Website http://www.zomedica.com
Updated 07/08/2019
Zomedica Pharmaceuticals Corp. is a pharmaceutical company, which targets health and wellness solutions for the companion pet (canine, feline and equine) through a ground-breaking approach that focuses on the needs of the veterinarians. Its building a diversified portfolio of products comprised of the discovery, development and commercialization of innovative drugs alongside novel drug delivery systems, devices and diagnostics. The company was founded on May 14, 2015 and is headquartered in Ann Arbor, MI.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.